Evidence map›Paper›PMID 26791568›Full record

ReviewWorld journal of surgical oncology2016

Papillary thyroid cancer located in malignant struma ovarii with omentum metastasis: a case report and review of the literature.

Yi Zhu, Chang Wang, Guo-Nan Zhang, Yu Shi, Shi-Qiang Xu, Shi-Jun Jia, Rong He

Abstract readCase ReportsReview
In one paragraph

Review in World journal of surgical oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Malignant struma ovarii: clinicopathological and molecular features in a series of nine cases.Virchows Archiv : an international journal of pathology · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yi ZhuDepartment of Gynecological Oncology, Sichuan Cancer Hospital, No. 55, Section 4, South People's Road, Chengdu, 610041, Sichuan, China. doczhuy@163.com.
Chang WangDepartment of Gynaecology and Obstetrics, Chengdu First People's Hospital, Chengdu, Sichuan, China. docwangc@163.com.
Guo-Nan ZhangDepartment of Gynecological Oncology, Sichuan Cancer Hospital, No. 55, Section 4, South People's Road, Chengdu, 610041, Sichuan, China. zhanggn@hotmail.com.
Yu ShiDepartment of Gynecological Oncology, Sichuan Cancer Hospital, No. 55, Section 4, South People's Road, Chengdu, 610041, Sichuan, China. lovejulie_2009@sina.com.
Shi-Qiang XuDepartment of Gynecological Oncology, Sichuan Cancer Hospital, No. 55, Section 4, South People's Road, Chengdu, 610041, Sichuan, China. julie.l.k@hotmail.com.
Shi-Jun JiaDepartment of Pathology, Sichuan Cancer Hospital, Chengdu, Sichuan, China. daxingxing-1@163.com.
Rong HeDepartment of Ultrasound, Sichuan Cancer Hospital, Chengdu, Sichuan, China. 410960600@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe present of malignant transformation in struma ovarii is exceedingly rare. Malignant struma ovarii is usually asymptomatic and infrequently diagnosed preoperatively. Because of its rarity, there is no consensus about diagnosis and management in the literature. CASE PRESENTATION: A 40-year-old female presented for her obstetric examination with an incidental finding of a pelvic mass. Patient was asymptomatic at presentation. A follow-up ultrasound confirmed the presence of a 3-cm mass in the left adnexa. Patient underwent a cytoreductive surgery (hysterectomy, bilateral salpingectomy and oophorectomy, omentectomy, appendectomy, and pelvic lymphadenectomy). Histopathology revealed a malignant struma ovarii with a focus of papillary thyroid carcinoma and the omentum metastasis. The patient with stage FIGO IIIc received 6 cycles of paclitaxel/carboplatin regimen after surgery. The patient subsequently had a thyroid scan that was normal with normal thyroid function. At a follow-up of 12 months, she is alive, in good clinical condition, and disease-free.

conclusionsBecause of the rarity of these tumors and their lack of firm prognostic factors, treatment decisions should be made individually, based on pathologic and clinical parameters.

Indexed as

OmentumAdultCarcinomaCarcinoma, PapillaryFemaleHumansOvarian NeoplasmsPeritoneal NeoplasmsStruma OvariiThyroid Cancer, PapillaryThyroid Neoplasms

Identifiers

PMID26791568
PMCPMC4721013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.